Journal of Clinical and Cellular Immunology
Open Access
ISSN: 2155-9899
ISSN: 2155-9899
Amina Dahmani, Cedric Carli, Manon Richaud, Valerie Janelle, Myriam Khalili, Mathieu Goupil and Jean-Sebastien Delisle
University of Montreal, Canada
Posters & Accepted Abstracts: J Clin Cell Immunol
Adoptive immunotherapy (AI) has emerged as a potentially curative therapy for advanced cancer and infections. Recent findings suggest that the transfer of T-cells with â??earlyâ? memory features may improve the therapeutic potential of AI. TGF-?² is a pleiotropic cytokine that controls a large spectrum of biological and pathological processes. In T-cell biology, TGF-?² is mostly known for its immunoregulatory properties, but recent evidence has revealed a novel role of TGF-?² in T-cell memory differentiation and maintenance. Thus, we investigated whether TGF-?² could promote features of memory in ex vivo stimulated human T-cells to further improve the efficacy of clinical protocols for AI. Here we show that agonistic TGF-?² stimulation leads to the expression of central memory markers without significantly altering T-cell expansion or polyfunctional cytokine secretion following stimulation. Furthermore, TGF-?² exposure decreased expression of transcription factors responsible for effector differentiation (T-BET, GATA3 and BLIMP1) and increased those associated with memory differentiation, notably ID3. The knock-down of ID3 by specific siRNA revealed that TGF-?²-driven T-cell memory differentiation largely depends on ID3. Moreover, TGF-?²-exposed T-cells showed enhanced persistence, expansion and alloreactivity after adoptive transfer into NSG mice. Finally, using clinically relevant culture methods to generate T-cell lines against viral and tumor antigens, we found that TGF-?² programmed the expression of early memory markers without significantly curtailing T-cell expansion or antigenspecificity. This finding provides a rationale for clinical use of TGF-?² to optimize memory phenotype of ex vivo pathogen/ antigen-specific T-cells expanded for AI.
Email: amina.dahmani1@gmail.com